Osako, T.; Kaiser, R.; Torii, K.; Uozumi, Y.; Synlett, 2019, 30, 961-966
Topographical mapping of isoform-selectivity determinants for J-channel-binding inhibitors of sphingosine kinases 1 and 2
Adams, D. R.; Tawati, S.; Berretta, G.; Rivas, P. L.; Baiget, J.; Jiang, Z.; Alsfouk, A.; MacKay, S. P.; Pyne, N.; Pyne, S.; J. Med. Chem., 2019, 62(7), 3658-3676
Preparation of HKUST-1@silica aerogel composite for continuous flow catalysis
Shalygin, A. S.; Nuzhdin, A. L.; Bukhtiyarova, G. A.; Martyanov, O. N.; J. Sol-Gel Sci. Technol., 2017, 84(3), 446-452
Doping carbon networks with phosphorus for supporting Pd in catalyzing selective oxidation of benzyl alcohol
Guo, W.; Niu, S.; Ji, X.; Yu, W.; Lin, T-W.; Wu, Y.; Li, Y.; Shao, L.; J. Nanopart. Res.; 2018, 20:180
SBA materials as support of iridium catalyst for hydrogenation reactions
Kiderys, A.; Kot, M.; Janiszewska, E.; Pietrowski, M.; Yang, C-M.; Zielinski, M.; Catalysis Today, 2019, accepted manuscript
Design and synthesis of multivalent α-1,2-trimannose-linked bioerodible microparticles for applications in immune response studies of Leishmania major infection
Rintelmann, C. R.; Grinnage-Pulley, T.; Ross, K.; Kabotso, D. E. K.; Toepp, A.; Cowell, A.; Petersen, C.; Narasimhan, B.; Pohl, N.; Beilstein J. Org. Chem., 2019, 15, 623-632
Atomic Cu on nanodiamond-based sp2/sp3 hybrid nanostructures for selective hydrogenation of phenylacetylene
Sun, Y.; Luo, B.; Xu, S.; Guo, W.; Huang, X.; Shao, L.; Chemical Physics Letters, 2019, 723, 39-43
Acylguanidine beta secretase 1 inhibitors: a combined experimental and free energy perturbation study
Keranen, H.; Perez-Benito, L.; Ciordia, M.; Delgado, F.; Steinbrecher, T. B.; Oehlrich, D.; van Vlijmen, H. W. T.; Trabanco, A. A.; Tresadern, G.; J. Chem. Theory Comput., 2017, 13, 1439-1453
Environmentally friendly synthesis of indoline derivatives using flow-chemistry techniques
Orkenyi, R.; Beke, G.; Riethmuller, E.; Szakacs, Z.; Koti, J.; Faigl, F.; Eles, J.; Greiner, I.; Eur. J. Org. Chem., 2017, 6525-6532
Discovery of a series of 8-(1-phenylpyrrolidin-2-yl)-6-carboxamide-2-morpholino-4H-chromen-4-one as PI3Kβ/δ inhibitors for the treatment of PTEN-deficient tumours
Barlaam, B.; Cosulich, S.; Degorce, S.; Ellston, R.; Fitzek, M.; Green, S.; Hancox, U.; Lambert-van der Brempt, C.; Lohmann, J-J.; Maudet, M.; Morgentin, M.; Ple, P.; Ward, L.; Warin, N.; Bioorg. Med. Chem. Lett., 2017, 27(9), 1949-1954